Drug · DIN 02279487
APIDRA
3ML OPTISET PRE-FILLED PEN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 7, 2017.
- Drug Identification Number (DIN)
- 02279487
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin glulisine A10AB06
- Class
- Human
- Record last updated
- June 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN GLULISINE (RECOMBINANT DNA ORIGIN) | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 12, 2006: NOC 7881New Drug Submission (NDS)
Other DINs named APIDRA
- DIN 02279460 · Marketed
- DIN 02279479 · Marketed
- DIN 02294346 · Marketed